Cargando…

The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease

The gut microbiome serves as a signaling hub that integrates environmental inputs with genetic and immune signals to influence the host’s metabolism and immunity. Gut bacteria are intricately connected with human health and disease state, with specific bacteria species driving the characteristic dys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiredu Ocansey, Dickson Kofi, Hang, Sanhua, Yuan, Xinyi, Qian, Hua, Zhou, Mengjiao, Valerie Olovo, Chinasa, Zhang, Xu, Mao, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980661/ https://www.ncbi.nlm.nih.gov/pubmed/36794838 http://dx.doi.org/10.1080/19490976.2023.2176118

Ejemplares similares

Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2021)

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
por: Xu, Xinwei, et al.
Publicado: (2022)

Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis
por: Wei, Zhiping, et al.
Publicado: (2023)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
por: Zhou, Mengjiao, et al.
Publicado: (2022)

Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review)
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2023)

Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2019)

Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer
por: Xia, Yuxuan, et al.
Publicado: (2023)

Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
por: Wang, Yifei, et al.
Publicado: (2022)

The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020)

The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases
por: Zhao, Zihan, et al.
Publicado: (2023)

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
por: Zhang, Yaqin, et al.
Publicado: (2021)

The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Xu, Xinwei, et al.
Publicado: (2021)

Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers
por: Wang, Naijian, et al.
Publicado: (2022)

Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases
por: Wei, Zhiping, et al.
Publicado: (2021)

The Effects of Mesenchymal Stem Cell on Colorectal Cancer
por: Yuan, Jintao, et al.
Publicado: (2021)

The effect of students’ online learning experience on their satisfaction during the COVID-19 pandemic: The mediating role of preference
por: Li, Xinchao, et al.
Publicado: (2023)

Improved therapeutics of modified mesenchymal stem cells: an update
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020)

Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis
por: Xu, Xinwei, et al.
Publicado: (2023)

Faecal microbial biomarkers in early diagnosis of colorectal cancer
por: Olovo, Chinasa Valerie, et al.
Publicado: (2021)

Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion
por: Shao, Xuejun, et al.
Publicado: (2022)

hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
por: Wang, Yifei, et al.
Publicado: (2023)

Exosome‐mediated effects and applications in inflammatory bowel disease
por: Ocansey, Dickson K. W., et al.
Publicado: (2020)

The deuce-ace of Lassa Fever, Ebola virus disease and COVID-19 simultaneous infections and epidemics in West Africa: clinical and public health implications
por: Nnaji, Nnabueze Darlington, et al.
Publicado: (2021)

Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases
por: Aggarwal, Surbhi, et al.
Publicado: (2021)

hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis
por: Cai, Xiu, et al.
Publicado: (2021)

Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease
por: Soontararak, Sirikul, et al.
Publicado: (2019)

Therapeutic Advances of Stem Cell-Derived Extracellular Vesicles in Regenerative Medicine
por: Yin, Lei, et al.
Publicado: (2020)

Microbial ecology and evolution is key to pandemics: using the coronavirus model to mitigate future public health challenges
por: Okeke, Emmanuel Sunday, et al.
Publicado: (2022)

The Role of Bacteriophages in the Gut Microbiota: Implications for Human Health
por: Emencheta, Stephen C., et al.
Publicado: (2023)

HucMSC‐exosomes carrying miR‐326 inhibit neddylation to relieve inflammatory bowel disease in mice
por: Wang, Gaoying, et al.
Publicado: (2020)

Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools?
por: Lacroix, Vickie, et al.
Publicado: (2021)

Predicting Inflammatory Bowel Disease Symptoms Onset: Nitrous Take on Gut Bacteria Is No Laughing Matter
por: Savidge, Tor
Publicado: (2020)

Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease
por: Vrakas, Spyros, et al.
Publicado: (2017)

Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease
por: Qv, Lingling, et al.
Publicado: (2021)

Gut Microbiota in Inflammatory Bowel Disease
por: Shim, Jung Ok
Publicado: (2013)

The gut microbiota and inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2014)

The Gut Microbiota in Inflammatory Bowel Disease
por: Qiu, Peng, et al.
Publicado: (2022)

Inflammatory Bowel Diseases and Gut Microbiota
por: Haneishi, Yuri, et al.
Publicado: (2023)

Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in Inflammatory Bowel Disease
por: Fornelos, Nadine, et al.
Publicado: (2020)

Prognostication in inflammatory bowel disease
por: Spencer, Elizabeth A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_toehor4c96m7l0l7et82gf2ka6